Gordian Biotechnology
Gordian Biotechnology is seeking a Principal Computational Biologist to lead the strategy and development of analytical frameworks for prioritizing therapeutic targets from large-scale in vivo perturbation screens. This role involves defining standardized methods, integrating multi-omics data, and collaborating with disease experts to drive target validation and drug discovery for age-related diseases. The position requires deep expertise in computational biology, machine learning, and single-cell transcriptomics to support translational research efforts.
Headquarters
South San Francisco, California, United States
Company Size
11-50 employees
Founded
2018
Gordian Biotechnology is a biotech company on a mission to cure complex age-related diseases through its proprietary in vivo drug discovery platform. The platform combines Patient Avatars (animal models that closely represent human patients), Mosaic Screening (pooled in vivo testing of hundreds of therapies), and Pythia (transcriptome-wide analysis of therapy effects across cellular pathways) to identify treatments most likely to succeed in human trials. Based in South San Francisco, Gordian focuses on discovering therapies that enable people to lead longer, healthier lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Gordian Biotechnology.
45% above the average for this role